1. Home
  2. PNTG vs TBPH Comparison

PNTG vs TBPH Comparison

Compare PNTG & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Pennant Group Inc.

PNTG

The Pennant Group Inc.

HOLD

Current Price

$33.85

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$18.90

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PNTG
TBPH
Founded
2019
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
PNTG
TBPH
Price
$33.85
$18.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
5
Target Price
$36.50
$29.20
AVG Volume (30 Days)
288.6K
418.7K
Earning Date
05-27-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
20.00
N/A
EPS
0.84
0.88
Revenue
$947,705,000.00
$15,386,000.00
Revenue This Year
$36.42
$70.90
Revenue Next Year
$23.99
N/A
P/E Ratio
$40.07
$20.64
Revenue Growth
36.31
N/A
52 Week Low
$21.18
$7.90
52 Week High
$35.00
$21.03

Technical Indicators

Market Signals
Indicator
PNTG
TBPH
Relative Strength Index (RSI) 63.02 46.39
Support Level $26.65 $18.27
Resistance Level N/A $19.04
Average True Range (ATR) 1.57 0.88
MACD 0.14 -0.13
Stochastic Oscillator 83.59 42.38

Price Performance

Historical Comparison
PNTG
TBPH

About PNTG The Pennant Group Inc.

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: